Tasly Pharmaceutical Group Co. Ltd.SSE: 600535

Preliminary Earnings Estimate for 2025

Feb 7, 2026 · Issued by Tasly Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Feb 7, 2026

On 6ix: 6ix.com/news/preliminary-earnings-estimate-for-2025-2

Preliminary Earnings Estimate for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Tasly Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Tasly Pharmaceutical

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic StandardJan 25
Announcement on Resolutions of the 6th Extraordinary General Meeting in 2025Dec 27, 2025
Announcement on Estimated Related Party Transactions of Daily Operations in 2026Dec 10, 2025
Announcement on Convening the Q3 2025 Performance BriefingNov 27, 2025
Announcement on Resolutions of the 15th Meeting of the 9th Board of DirectorsOct 25, 2025

Later from Tasly Pharmaceutical

Announcement on Resignation of Senior Management MemberMar 7
Announcement on Annual Key Operating Data Report for 2025Mar 20
Announcement on Guarantee Estimate for 2026Mar 24
Announcement on Resolutions of the 2025 Annual General MeetingApr 18
Announcement on Change of Accounting PoliciesApr 25

All Tasly Pharmaceutical news releases

Follow Tasly Pharmaceutical into a list and get an email when it puts out news.

Follow Tasly Pharmaceutical